Locus: AT5G66675 (Chromosome 5, Arabidopsis thaliana)
Functional Classification: Domain of Unknown Function 677 (DUF677), which lacks experimentally validated functional data
A transcriptome analysis comparing wild-type (WT) and rpt2a mutant Arabidopsis plants revealed:
| AGI Code | Description | WT dS/WT nS | p-value | rpt2 dS/rpt2 nS | p-value |
|---|---|---|---|---|---|
| AT5G66675 | hypothetical protein | -1.28 | 0.0552 | -1.89 | 8.80E-06 |
| AT5G66817 | unrelated protein | 1.11 | — | — | — |
This table indicates reduced expression of AT5G66675 in both WT and rpt2a mutants under tested conditions .
While antibodies against plant proteins like MIPS1, MIPS2, and MIPS3 have been successfully generated (e.g., for studying subcellular localization in endosperm) , no analogous efforts are documented for AT5G66675. Key barriers include:
Lack of Functional Data: DUF677 domains lack characterized roles, complicating antigen selection .
Low Expression Levels: Transcriptomic data suggest minimal expression under standard growth conditions .
Structural Uncertainty: Transmembrane domains often hinder antigen design due to hydrophobicity and conformational variability .
If an AT5G66675 antibody were developed, it could enable:
Subcellular Localization Studies: Confirming transmembrane topology .
Protein Interaction Networks: Identifying partners via immunoprecipitation (e.g., effector-target networks as seen in plant-pathogen studies) .
Mutant Phenotyping: Validating gene knockout/knockdown lines .
For future antibody development, strategies include:
Epitope Selection: Prioritize hydrophilic regions predicted by tools like Antibody Epitope Prediction .
Expression Systems: Use recombinant AT5G66675 fragments (e.g., extracellular loops) as immunogens .
Validation: Pair with orthogonal methods (e.g., CRISPR-Cas9 tagging or mass spectrometry) .
Here’s a structured, research-focused FAQ for At5g66675 Antibody based on academic literature and experimental methodologies:
Epitope Mapping: Synthesize peptide arrays covering At5g66675’s variable regions (e.g., residues 120-180). Test antibody binding against overlapping 15-mer peptides .
Competitive ELISA: Pre-incubate antibody with recombinant At3g12910 protein; >90% signal reduction indicates cross-reactivity .
Method: Confocal microscopy of transgenic lines (e.g., pAt5g66675:At5g66675-GFP) treated with NaCl (150 mM) or mannitol (300 mM). Use organelle markers (e.g., RFP-H2B for nucleus) .
Quantification: Measure nuclear/cytoplasmic fluorescence ratios using FIJI/ImageJ (n ≥ 30 cells per condition) .
Hypothesis: Post-translational regulation or antibody cross-reactivity with stress-induced isoforms.
Validation: Perform RNAi knockdown in leaves and quantify protein via parallel reaction monitoring (PRM) MS .